BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee D, Lee WY, Jung K, Kwon YS, Kim D, Hwang GS, Kim CE, Lee S, Kang KS. The Inhibitory Effect of Cordycepin on the Proliferation of MCF-7 Breast Cancer Cells, and its Mechanism: An Investigation Using Network Pharmacology-Based Analysis. Biomolecules 2019;9:E407. [PMID: 31450828 DOI: 10.3390/biom9090407] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Quan X, Kwak BS, Lee JY, Park JH, Lee A, Kim TH, Park S. Cordyceps militaris Induces Immunogenic Cell Death and Enhances Antitumor Immunogenic Response in Breast Cancer. Evid Based Complement Alternat Med 2020;2020:9053274. [PMID: 32963576 DOI: 10.1155/2020/9053274] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Man S, Lu Y, Yin L, Cheng X, Ma L. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today 2021;26:1490-500. [PMID: 33639248 DOI: 10.1016/j.drudis.2021.02.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lee HS, Lee IH, Kang K, Park SI, Moon SJ, Lee CH, Lee DY. A Network Pharmacology Study on the Molecular Mechanisms of FDY003 for Breast Cancer Treatment. Evid Based Complement Alternat Med 2021;2021:3919143. [PMID: 33628298 DOI: 10.1155/2021/3919143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chen W, Cheng H, Chen L, Zhan X, Xia W. Synthesis, characterization, and anti-tumor properties of O-benzoylselenoglycolic chitosan. Int J Biol Macromol 2021;193:491-9. [PMID: 34678382 DOI: 10.1016/j.ijbiomac.2021.10.086] [Reference Citation Analysis]
5 Wong JH, Ng TB, Chan HHL, Liu Q, Man GCW, Zhang CZ, Guan S, Ng CCW, Fang EF, Wang H, Liu F, Ye X, Rolka K, Naude R, Zhao S, Sha O, Li C, Xia L. Mushroom extracts and compounds with suppressive action on breast cancer: evidence from studies using cultured cancer cells, tumor-bearing animals, and clinical trials. Appl Microbiol Biotechnol 2020;104:4675-703. [PMID: 32274562 DOI: 10.1007/s00253-020-10476-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
6 Das G, Shin HS, Leyva-Gómez G, Prado-Audelo MLD, Cortes H, Singh YD, Panda MK, Mishra AP, Nigam M, Saklani S, Chaturi PK, Martorell M, Cruz-Martins N, Sharma V, Garg N, Sharma R, Patra JK. Cordyceps spp.: A Review on Its Immune-Stimulatory and Other Biological Potentials. Front Pharmacol 2020;11:602364. [PMID: 33628175 DOI: 10.3389/fphar.2020.602364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Song Y, Wang H, Pan Y, Liu T. Investigating the Multi-Target Pharmacological Mechanism of Hedyotis diffusa Willd Acting on Prostate Cancer: A Network Pharmacology Approach. Biomolecules 2019;9:E591. [PMID: 31600936 DOI: 10.3390/biom9100591] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
8 Yu C, Li Y, Chen G, Wu C, Wang X, Zhang Y. Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges. J Zhejiang Univ Sci B 2022;23:547-63. [PMID: 35794685 DOI: 10.1631/jzus.B2101019] [Reference Citation Analysis]
9 Niego AG, Rapior S, Thongklang N, Raspé O, Jaidee W, Lumyong S, Hyde KD. Macrofungi as a Nutraceutical Source: Promising Bioactive Compounds and Market Value. J Fungi (Basel) 2021;7:397. [PMID: 34069721 DOI: 10.3390/jof7050397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Lee WY, Lee CY, Kim CE, Kim JH. Investigating the Biomarkers of the Sasang Constitution via Network Pharmacology Approach. Evid Based Complement Alternat Med 2021;2021:6665130. [PMID: 33936241 DOI: 10.1155/2021/6665130] [Reference Citation Analysis]